Patients with high-risk advanced ovarian cancer obtained a marginal survival benefit with the addition of bevacizumab ...

Ovarian cancer, often diagnosed late due to subtle symptoms, sees significantly improved survival rates with early detection.

The U.S. Food and Drug Administration has approved Verastem's combination therapy for patients with a rare type of ovarian ...

For ovarian cysts that cause pain, medications such as acetaminophen, ibuprofen, or another non-steroidal anti-inflammatory ...

Manisha Koirala was diagnosed with stage IV ovarian cancer in 2012. She later made a recovery after undergoing treatment in ...

Ovarian cancer remains the leading cause of death among cancers affecting the female reproductive system, largely because ...

In line with previous clinical trial findings, real-world data show that bevacizumab improves outcomes in patients with ...

A panelist discusses how antibody-drug conjugates like mirvetuximab should be sequenced in platinum-resistant ovarian cancer, ...

A real-world study based on information from an electronic health records–derived database reveals limited benefits of adding ...

Merck (NYSE:MRK) announced Thursday that its bestselling therapy, Keytruda, as part of a combination regimen, reached the ...

The seventh warning indicator of poor ovary health or ovarian cancer is a visible change in the bowel movement. Studies have ...

Ovarian cancer, a significant threat to women over 50, often goes undetected early. While there's no foolproof prevention, ...